All Updates

All Updates

icon
Filter
Product updates
DeepMind launches updated version of AlphaFold model for drug discovery
AI Drug Discovery
Oct 31, 2023
This week:
Product updates
Pimax announces compact Dream Air VR headset for USD 1,900
Extended Reality
Dec 23, 2024
Funding
HuLoop raises Series A funding from Mighty Capital
Workflow Automation Platforms
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
Financial Wellness Tools
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
FinTech Infrastructure
Dec 23, 2024
Funding
Meight raises EUR 3.4 million in funding led by Cusp Capital
Smart Mobility Information
Dec 23, 2024
Regulation/policy
Desktop Metal sues Nano Dimension over merger compliance
Additive Manufacturing
Dec 23, 2024
Management news
Nexa3D scales back operations amid financial crisis
Additive Manufacturing
Dec 23, 2024
Funding
Fraction AI raises USD 6 million in pre-seed funding to scale hybrid data labeling
Machine Learning Infrastructure
Dec 23, 2024
Last week:
Partnerships
Rocket Lab launches sixth Synspective radar satellite as part of ongoing partnership
Space Travel and Exploration Tech
Dec 21, 2024
Partnerships
EHang partners with Changan Automobile to develop eVTOL aircraft for personal transportation
Passenger eVTOL Aircraft
Dec 21, 2024
AI Drug Discovery

AI Drug Discovery

Oct 31, 2023

DeepMind launches updated version of AlphaFold model for drug discovery

Product updates

  • Alphabet-owned AI company DeepMind has released an updated version of its AI system, AlphaFold, which can accurately predict the structures of proteins and other biological molecules. The system is leveraged by DeepMind's spin-off company, Isomorphic Labs for drug discovery.

  • The updated AlphaFold can predict the structures of proteins without any reference protein, whereas the previous versions required a docking protein to carry out these functions. In addition, this version can predict ligands, nucleic acids, and post-translational modifications. This can aid in drug discovery by identifying and designing new molecules with therapeutic potential.

  • DeepMind claims that its new AlphaFold model outperforms previous versions and shows the potential for AI to enhance scientific understanding of the human body's molecular machines. However, the system still falls short in predicting the structures of RNA molecules.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.